A carregar...
Cost‐effectiveness of long‐acting insulin analogues vs intermediate/long‐acting human insulin for type 1 diabetes: A population‐based cohort followed over 10 years
AIMS: This study assessed the cost‐effectiveness of long‐acting insulin analogues (LAIAs) vs intermediate/long‐acting human insulin (ILAHI) for patients with type 1 diabetes (T1D) in real‐world clinical practice. METHODS: Individual‐level analyses were conducted within a longitudinal population‐base...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7163379/ https://ncbi.nlm.nih.gov/pubmed/31782975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14188 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|